CalmiGo Overview
CalmiGo is a drug-free device designed to provide immediate relief during moments of anxiety and distress by regulating the user’s breathing patterns and senses, thereby alleviating symptoms on the spot. CalmiGo uses three proven techniques to decrease stress hormone levels by enabling the body to quiet the stressful sympathetic nervous system while activating the calming parasympathetic nervous system through the use of personalized breathing regulation, multisensory stimulation, and soothing scents. CalmiGo was developed by Dendro Technologies Inc.
Cumulative Funding Raised Over Time ($)
—Dec 2024
$6.0MJan 2024
$6.0MMar 2021
Latest News
growth-positive
כאוס בוועדה המייעצת לחיסונים בארה"ב ● אייל ולדמן וד"ר מרטין רוזנצוייג מצטרפים לדירקטוריון חברת Calmigo ● ביולייט, המתמחה בפיתוח תרופות ומכשור רפואי בתחום מחלות העיניים, הודיעה על גיוס של 20 מיליון שקל ● חוקרים ממכללת עזריאלי להנדסה והאוניברסיטה העברית פיתחו מודל תלת-ממד, המדמה את רירית הרחם האישית של מטופלות פוריות ● תאגיד רוש, בית החולים שיבא וארגון סטארט-אפ ניישן סנטרל, הכריזו על תכנית לאיתור טכנולוגיה ישראלית פורצת דרך בתחום סרטן השד ● השבוע בביומד
BioLight, a company specializing in the development of drugs and medical devices for eye diseases, announced a successful capital raise of 20 million shekels through a shelf prospectus. Prior to the announcement, the companys market value was 19 million shekels, which doubled to 39 million shekels following the offering. The offering included shares and options, with the companys stock experiencing a 32% drop upon the announcement but recovering slightly afterward. BioLights portfolio includes several companies in various stages of clinical trials, with a focus on eye disease treatments. The company has completed two exits and holds significant stakes in other ventures, estimating its portfolios value at 497 million shekels.
Investment
growth-positive
CalmiGo donated 1,300 of its technological devices, providing immediate relief from panic attacks and PTSD | CTech
Adi Wallach, a Biomedical Engineering graduate at the Technion, developed an AI-based device, CalmiGo, to help people suffering from anxiety, panic attacks, PTSD, and stress. The device, which helps regulate breathing and releases soothing scents, has been proven effective in four clinical trials and is used by over 95,000 users in Israel and America. Following the events of October 7, CalmiGo donated 1,300 devices to trauma victims. The devices are fully subsidized for residents of the south and victims of the conflict, and distribution is done through therapists, treatment centers, and direct distribution to the victims.
CustomersPartners
growth-positive
חשבתי שאני משתגעת, נפרדתי מההורים: מהתקף חרדה בקולנוע לגיוס של 5 מיליון דולר
The article discusses the personal experience of Adi Velach, the founder of Dandaro, a mental health company. Adi shares her experience of anxiety and dissociation, which led her to create the company. Dandaro aims to bridge the gap between traditional medicine and alternative treatments. The company was founded in 2018 and has raised $5.4 million in funding. The article highlights the importance of addressing mental health issues and the need for alternative approaches. The date of the event described in the article is October 12, 2021.
CustomersInvestment
growth-positive
CalmiGo, On-the-spot Aid For Anxiety, Is Now Available At Select CVS Health Stores Nationwide
CalmiGo, a portable exhaler designed to relieve anxiety and stress, is now available at 800 CVS Health stores nationwide. The device, launched in 2020, fills the gap between prescription drugs and unproven alternative solutions. CalmiGo regulates breathing patterns and stimulates the four senses to restore calm within 3 minutes of use. It is proven to help manage stress and anxiety in various situations and is safe for people of all ages. The device is currently the subject of clinical studies and has sold over 40,000 devices to date. CalmiGo is backed by leading investors and an advisory board that includes experts from major pharmaceutical, consumer health, and medical device companies.
Customers
growth-positive
This Handheld Inhaler Helps Fight Anxiety Attacks Without Any Drugs
Dendro Technologies has developed a tiny inhaler-like device to help individuals breathe properly during anxiety attacks. The device, called Calmigo, is fitted with battery-powered hardware that enforces normal breathing patterns. Users breathe into the device until a series of green lights appear, indicating the correct pace for breathing. The device can also release relaxing aromas. Trials have been conducted at Lenox Hill Hospital and the Mayo Clinic, targeting panic disorder and stress management in heart attack patients, respectively. The device is seen as a drug-free, early intervention, and long-term treatment option for anxiety and panic attack symptoms.
Customers
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | $6M |
| Last funding | Undisclosed |
| Stage | A |
| Rounds | 3 |
| Investors | 6 |
Team Members
3
Employees: 11-50
Web & Social Links
| Website | calmigo.com/ |
Locations
Ha-Melakha St 45, Netanya, Israel
430 W 116th St, New York, NY 10027, USA
Photos & Videos
1 item(s)
CalmiGo Business
Business models
B2C
Product stage
Released
Employees
11-50
Sector
Health Tech & Life SciencesMedical DevicesMedical Treatment & TherapeuticsTarget Customer
Healthcare & Life SciencesHealthcarePatientsCore Technology
Semiconductors & ElectronicsDigital Signal ProcessorSensingVibrationTags (4)
mental-healthmedical-devicesneuro-stimulationneurologyGeographic Markets
United StatesIsraelCalmiGo Financials
$6M
Total funding
Undisclosed
Capital raised
Undisclosed
Last funding
A
Funding stage
3
Total rounds
6
Investors
Cumulative Funding Raised Over Time ($)
—Dec 2024
$6.0MJan 2024
$6.0MMar 2021
Private Equity Funding
A Round
Dec 2024
Undisclosed
J-Ventures
Seed
Jan 2024
$6M
Grove Ventures
Seed
Mar 2021
Undisclosed
Welltech Ventures (Lead)
,
2B-Community, Jibe Ventures, 5eyes Ventures
CalmiGo Lifecycle
Cumulative Funding Raised Over Time
—Dec 2024
$6.0MJan 2024
$6.0MMar 2021
All Events
A Round
Dec 2024
Undisclosed
J-Ventures
Seed
Jan 2024
$6M
Grove Ventures
Seed
Mar 2021
Undisclosed
Welltech Ventures (Lead)
,
2B-Community, Jibe Ventures, 5eyes Ventures
CalmiGo News
6 articles
growth-positive
כאוס בוועדה המייעצת לחיסונים בארה"ב ● אייל ולדמן וד"ר מרטין רוזנצוייג מצטרפים לדירקטוריון חברת Calmigo ● ביולייט, המתמחה בפיתוח תרופות ומכשור רפואי בתחום מחלות העיניים, הודיעה על גיוס של 20 מיליון שקל ● חוקרים ממכללת עזריאלי להנדסה והאוניברסיטה העברית פיתחו מודל תלת-ממד, המדמה את רירית הרחם האישית של מטופלות פוריות ● תאגיד רוש, בית החולים שיבא וארגון סטארט-אפ ניישן סנטרל, הכריזו על תכנית לאיתור טכנולוגיה ישראלית פורצת דרך בתחום סרטן השד ● השבוע בביומד
BioLight, a company specializing in the development of drugs and medical devices for eye diseases, announced a successful capital raise of 20 million shekels through a shelf prospectus. Prior to the announcement, the companys market value was 19 million shekels, which doubled to 39 million shekels following the offering. The offering included shares and options, with the companys stock experiencing a 32% drop upon the announcement but recovering slightly afterward. BioLights portfolio includes several companies in various stages of clinical trials, with a focus on eye disease treatments. The company has completed two exits and holds significant stakes in other ventures, estimating its portfolios value at 497 million shekels.
Investment
growth-positive
CalmiGo donated 1,300 of its technological devices, providing immediate relief from panic attacks and PTSD | CTech
Adi Wallach, a Biomedical Engineering graduate at the Technion, developed an AI-based device, CalmiGo, to help people suffering from anxiety, panic attacks, PTSD, and stress. The device, which helps regulate breathing and releases soothing scents, has been proven effective in four clinical trials and is used by over 95,000 users in Israel and America. Following the events of October 7, CalmiGo donated 1,300 devices to trauma victims. The devices are fully subsidized for residents of the south and victims of the conflict, and distribution is done through therapists, treatment centers, and direct distribution to the victims.
CustomersPartners
growth-positive
חשבתי שאני משתגעת, נפרדתי מההורים: מהתקף חרדה בקולנוע לגיוס של 5 מיליון דולר
The article discusses the personal experience of Adi Velach, the founder of Dandaro, a mental health company. Adi shares her experience of anxiety and dissociation, which led her to create the company. Dandaro aims to bridge the gap between traditional medicine and alternative treatments. The company was founded in 2018 and has raised $5.4 million in funding. The article highlights the importance of addressing mental health issues and the need for alternative approaches. The date of the event described in the article is October 12, 2021.
CustomersInvestment
growth-positive
CalmiGo, On-the-spot Aid For Anxiety, Is Now Available At Select CVS Health Stores Nationwide
CalmiGo, a portable exhaler designed to relieve anxiety and stress, is now available at 800 CVS Health stores nationwide. The device, launched in 2020, fills the gap between prescription drugs and unproven alternative solutions. CalmiGo regulates breathing patterns and stimulates the four senses to restore calm within 3 minutes of use. It is proven to help manage stress and anxiety in various situations and is safe for people of all ages. The device is currently the subject of clinical studies and has sold over 40,000 devices to date. CalmiGo is backed by leading investors and an advisory board that includes experts from major pharmaceutical, consumer health, and medical device companies.
Customers
growth-positive
This Handheld Inhaler Helps Fight Anxiety Attacks Without Any Drugs
Dendro Technologies has developed a tiny inhaler-like device to help individuals breathe properly during anxiety attacks. The device, called Calmigo, is fitted with battery-powered hardware that enforces normal breathing patterns. Users breathe into the device until a series of green lights appear, indicating the correct pace for breathing. The device can also release relaxing aromas. Trials have been conducted at Lenox Hill Hospital and the Mayo Clinic, targeting panic disorder and stress management in heart attack patients, respectively. The device is seen as a drug-free, early intervention, and long-term treatment option for anxiety and panic attack symptoms.
Customers
Not applicable
The Calmigo: A Device to Calm Anxiety on the Go
The article discusses a device designed to alleviate anxiety and panic. The device works by activating the users senses to calm them down. The owner of the product is interviewed.
Not applicable
CalmiGo Team
Employee Info
| Employees (range) | 11-50 |
| Exact count | 25 |
| Team members | 3 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
This entity has 9 classification IDs that could be used for matching.
CalmiGo Internal
Recent Updates
No update log entries.
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 93/100 |
| Missing | markets, not claimed |
| BI Verification | Yanina Wainscheinker |
| Registrar ID | 516368784 |
| Creator | Dana Arnon |
| Creator email | dana.arnon@mail.huji.ac.il |
| Last updater | Yanina Wainscheinker |
| Updater email | yanina.wainscheinker@sncentral.org |
| Last update | 2024-07-08T00:00:00.000Z |
| Created | 2022-10-30T00:00:00.000Z |